BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen D, Xie S, Wu Y, Cui Y, Cai Y, Lan L, Yang H, Chen J, Chen W. Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1. Front Oncol 2020;10:572672. [PMID: 33643896 DOI: 10.3389/fonc.2020.572672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li F, Zheng Z, Chen W, Li D, Zhang H, Zhu Y, Mo Q, Zhao X, Fan Q, Deng F, Han C, Tan W. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat 2023;68:100938. [PMID: 36774746 DOI: 10.1016/j.drup.2023.100938] [Reference Citation Analysis]
2 Das S, Hayden J, Sullivan T, Rieger-Christ K. The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment. Int J Mol Sci 2023;24. [PMID: 36674480 DOI: 10.3390/ijms24020964] [Reference Citation Analysis]
3 Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi MP, Mazzarelli F, Melocchi V, Palumbo O, Marino E, Belloni E, Montani F, Vecchi M, Barberis M, Graziano P, Pasquier A, Sanz-Ortega J, Montuenga LM, Carbonelli C, Spaggiari L, Bianchi F. miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response. J Hematol Oncol 2022;15:178. [PMID: 36587234 DOI: 10.1186/s13045-022-01394-1] [Reference Citation Analysis]
4 Murphy N, Shih AJ, Shah P, Yaskiv O, Khalili H, Liew A, Lee AT, Zhu XH. Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer. Oncotarget 2022;13:1188-200. [PMID: 36322407 DOI: 10.18632/oncotarget.28302] [Reference Citation Analysis]
5 Lou T, Zhang L, Jin Z, Miao C, Wang J, Ke K. miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1. Open Medicine 2022;17:847-56. [DOI: 10.1515/med-2022-0474] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chen X, Zhang Y, Wang F, Zhou X, Fu Q, Yang X, Lin J, Jin X. A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer. Front Cell Dev Biol 2021;9:718991. [PMID: 34869309 DOI: 10.3389/fcell.2021.718991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhao Y, Yao R. Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p. Bioengineered 2021;12:8724-37. [PMID: 34698001 DOI: 10.1080/21655979.2021.1978196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu T, Hu J, Han B, Tan S, Jia W, Xin Y. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma. Cell Death Dis 2021;12:952. [PMID: 34657141 DOI: 10.1038/s41419-021-04245-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]